开发一种活体减弱的仿制疫苗,对抗新出现的乌苏图病毒
Zheng-Jian Wang1, Rong-Rong Zhang1, Mei Wu1
1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
Vaccine
|February 3, 2024
概括
在临床前研究中,一种新的仿制乌苏图病毒 (USUV) 疫苗ChinUSUV在临床前研究中显示出显著的安全性和有效性. 这种活体减弱疫苗候选为预防USUV感染提供了一个有希望的新方法.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
背景情况:
- 乌苏图病毒 (USUV) 是一种新兴的病毒,在人类中引起神经系统并发症.
- 目前没有针对USUV的疫苗,这凸显了预防措施的迫切需要.
研究的目的:
- 开发和评估一种活体减弱化学USUV疫苗 (ChinUSUV).
- 评估ChinUSUV.的安全性,免疫性和保护性疗效.
主要方法:
- 使用日本脑炎病毒 (JEV) 疫苗骨干构建一个虚构的USUV疫苗.
- 在体外复制和遗传稳定性评估.
- 在多个小鼠模型中的体内评估,包括免疫性和保护性研究.
主要成果:
- 在试验室中,ChinUSUV证明了有效的复制和遗传稳定性.
- 该疫苗在小鼠模型中显示出显著的衰减,超过了JEV疫苗.
- 一次免疫接种诱导了强大的幽默和细胞免疫反应.
- 被动抗体转移提供了对致命的USUV挑战的保护.
结论:
- 中国USUV是乌苏图病毒的有希望的活体减弱疫苗候选人.
- 为了潜在的人类用途,需要进一步开发ChinUSUV.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.4K
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
12.6K
相关概念视频
00:42Cross-reactivity
Overview
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...